Both in Biotechnology
Pelthos Therapeutics vs ImageneBio
Over the past year PTHS returned −70.8% and IMA returned −50.2%; their daily moves had a correlation of 0.03.
PTHS −70.8% IMA −50.2%Growth of $1, one year, split-adjusted
| Metric | PTHS | IMA |
|---|---|---|
| Price | $10.15 | $4.10 |
| Market cap | $39.9M | $46.5M |
| Today | −5.84% | +1.99% |
| 1 month | −52.7% | −10.9% |
| 6 months | −59.4% | −32.6% |
| Year to date | −67.3% | −40.6% |
| 1 year | — | −51.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 76.9% | — |
| Net margin | −150.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | -$45.7M | $136.2M |
| Dividend yield | — | — |
| Volatility (60d) | 140.7% | 37.5% |
| Short % of float | 8.6% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).